ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Missouri » Internal Medicine

Top Internal Medicine Prescribers in Missouri

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
ABDULLAH ARSHAD MD

Internal Medicine

73,575

$4.47M

1412
602 are 65+

2%
patients receiving schedule two controlled substances

Avg: 5%

18%
patients receiving schedule three controlled substances

Avg: 12%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 24%

$61
Average prescription price

Avg: $56

CHRISTOPHER LABONTE MD

Internal Medicine

67,515

$4.76M

1098
597 are 65+

10%
patients receiving schedule two controlled substances

Avg: 5%

14%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 24%

$71
Average prescription price

Avg: $56

REZA JALAL MD

Internal Medicine

50,829

$2.95M

992
809 are 65+

8%
patients receiving schedule two controlled substances

Avg: 5%

30%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 24%

$58
Average prescription price

Avg: $56

BINWANT SINGH M.D.

Internal Medicine

50,086

$3.65M

943
389 are 65+

6%
patients receiving schedule two controlled substances

Avg: 5%

17%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 24%

$73
Average prescription price

Avg: $56

DONALD PILAND M.D.

Internal Medicine

43,518

$2.11M

1163
871 are 65+

3%
patients receiving schedule two controlled substances

Avg: 5%

17%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$49
Average prescription price

Avg: $56

RAMILO GATAPIA MD

Internal Medicine

40,820

$2.54M

715
577 are 65+

16%
patients receiving schedule two controlled substances

Avg: 5%

29%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$62
Average prescription price

Avg: $56

STEPHEN WELTON M.D.

Internal Medicine

36,806

$2.41M

749
575 are 65+

4%
patients receiving schedule two controlled substances

Avg: 5%

40%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 24%

$65
Average prescription price

Avg: $56

ARNOLD TEPPER MD

Internal Medicine

35,656

$1.81M

943
802 are 65+

7%
patients receiving schedule two controlled substances

Avg: 5%

14%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$51
Average prescription price

Avg: $56

RICHARD CHUNG M.D.

Internal Medicine

33,935

$1.78M

524
470 are 65+

17%
patients receiving schedule two controlled substances

Avg: 5%

35%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$53
Average prescription price

Avg: $56

IFTIKHAR ALI MD

Internal Medicine

33,292

$1.88M

814
552 are 65+

10%
patients receiving schedule two controlled substances

Avg: 5%

23%
patients receiving schedule three controlled substances

Avg: 12%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$56
Average prescription price

Avg: $56

EHAB KAISER M.D.

Internal Medicine

32,025

$1.59M

838
750 are 65+

7%
patients receiving schedule two controlled substances

Avg: 5%

16%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$50
Average prescription price

Avg: $56

MONA TOMESCU M.D.

Internal Medicine

31,873

$2.8M

589
265 are 65+

17%
patients receiving schedule two controlled substances

Avg: 5%

42%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

36%
prescriptions for brand name drugs

Avg: 24%

$88
Average prescription price

Avg: $56

FELIPE ELJAIEK M.D.

Internal Medicine

30,873

$1.62M

1143
739 are 65+

7%
patients receiving schedule two controlled substances

Avg: 5%

18%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$53
Average prescription price

Avg: $56

ASHUTOSH PATEL MD

Internal Medicine

30,864

$1.48M

876
633 are 65+

7%
patients receiving schedule two controlled substances

Avg: 5%

18%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$48
Average prescription price

Avg: $56

JOSE REMO MD

Internal Medicine

30,385

$1.56M

1068
732 are 65+

9%
patients receiving schedule two controlled substances

Avg: 5%

19%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$51
Average prescription price

Avg: $56

KHALED HASSAN MD

Internal Medicine

30,146

$1.77M

606
386 are 65+

24%
patients receiving schedule two controlled substances

Avg: 5%

23%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$59
Average prescription price

Avg: $56

STEPHEN NAGY M.D.

Internal Medicine

29,894

$1.94M

745
563 are 65+

9%
patients receiving schedule two controlled substances

Avg: 5%

29%
patients receiving schedule three controlled substances

Avg: 12%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 24%

$65
Average prescription price

Avg: $56

TIMOTHY RYAN D.O.

Internal Medicine

29,130

$1.66M

826
588 are 65+

15%
patients receiving schedule two controlled substances

Avg: 5%

11%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$57
Average prescription price

Avg: $56

ANGELA PATTERSON M.D.

Internal Medicine

27,454

$1.31M

748
493 are 65+

4%
patients receiving schedule two controlled substances

Avg: 5%

32%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$48
Average prescription price

Avg: $56

DANIEL BARNETT MD

Internal Medicine

27,435

$1.51M

876
699 are 65+

7%
patients receiving schedule two controlled substances

Avg: 5%

22%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$55
Average prescription price

Avg: $56

ALKA KAPOOR MD

Internal Medicine

26,864

$1.4M

505
482 are 65+

11%
patients receiving schedule two controlled substances

Avg: 5%

20%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$52
Average prescription price

Avg: $56

ELLIS BERKOWITZ M.D.02

Internal Medicine

26,765

$1.28M

960
822 are 65+

6%
patients receiving schedule two controlled substances

Avg: 5%

20%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$48
Average prescription price

Avg: $56

SEAN MCLAUGHLIN M.D.

Internal Medicine

26,250

$1.08M

996
890 are 65+

4%
patients receiving schedule two controlled substances

Avg: 5%

11%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 24%

$41
Average prescription price

Avg: $56

YUSUF CHAUDHRY M.D.

Internal Medicine

26,230

$1.49M

577
304 are 65+

12%
patients receiving schedule two controlled substances

Avg: 5%

34%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 24%

$57
Average prescription price

Avg: $56

R RANDALL SUKMAN M.D.

Internal Medicine

25,836

$1.48M

863
599 are 65+

15%
patients receiving schedule two controlled substances

Avg: 5%

22%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$57
Average prescription price

Avg: $56

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank